Advestra advised Galderma on its inaugural bonds in the aggregate principal amount of CHF 500 million. The payment date of the bonds is September 27, 2024. The bonds will be listed on the SIX Swiss Exchange and are
Tags :Valérie Bayard
Advestra advised Novartis on the issuance of CHF 2.2 billion bonds, placed in five tranches as follows: UBS, BNP Paribas (Suisse) and Deutsche Bank Aktiengesellschaft acted as joint lead managers
Lonza Swiss Finance, a wholly owned subsidiary of the Lonza Group, has successfully placed CHF 300 million 2.1% guaranteed senior bonds due 2029. Credit Suisse, UBS
Xlife Sciences successfully listed its shares on the standard “Sparks” of SIX Swiss Exchange — making it the very first listing on the new and regulated SME
SIG Combibloc, a leading systems and solutions provider for aseptic carton packaging, has entered into an agreement to acquire Pactiv Evergreen’s Asia Pacific
On October 27, 2021, Skan Group has announced the pricing of its IPO, consisting of 1,731,494 newly issued shares and 2,768,506 existing shares and an over-allotment option of up to 500,000 shares, at CHF 54 per share, implying a total market
Bachem Holding, an innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides, has raised CHF 583.5 million through an accelerated bookbuilding process by issuing 750,000 new shares at a placement price of CHF 778 per
MLL acted as legal partner of Värdex Suisse for the cryptonow voucher card offering and advsied in particular in connection with Swiss financial market regulatorions and contractual law. The MLL team was led by
